Peripheral Nervous System Drugs

Slides:



Advertisements
Similar presentations
INDIRECT CHOLINOMIMETICS Pharmacology Department
Advertisements

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Drugs Affecting Peripheral Nervous System #2. Fight or Flight versus the Parasympathetic Pig.
ANTICHOLINERGIC DRUGS Pharmacology Department
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Autonomic Nervous System Drugs
Adrenergic & Adrenergic-blocking Agents
Chapter 5 Autonomic Drugs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.
Lecture 3 Autonomic Nervous System. Chapter 20 Autonomic Nervous System n n Central Nervous System (CNS) - Brain and spinal cord n n Peripheral Nervous.
Alpha-Adrenergic Blockers
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Cholinergic agonists & Cholinergic antagonists
Cholinergics, anticholinergics and antcholinesterases Nervous System Peripheral NS Sensory nerves Motor nerves Central NS (Brain and Spinal cord) Sensory.
Adrenoceptor Blockers
Drugs Affecting the Sympathetic Nervous System
ADRENERGIC ANTAGONITS
Autonomic Nervous System
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM 10/8/2015Winter
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 19 Indirect-Acting Antiadrenergic Agents.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
AUTONOMIC SYSTEMS AND DRUGS-2
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 13 Autonomic Nervous System Drugs.
INDIRECT CHOLINOMIMETICS
Chapter 33 Agents Affecting the Autonomic Nervous System.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Cholinergic drugs.
Cholinergic antagonists
ANTICHOLINERGIC DRUGS
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
AUTONOMIC NERVOUS SYSTEM LECTURE 6 PHARMACOLOGY. Autonomic Pharmacology Autonomic Nervous System – This system is divided into two separate systems. –
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Autonomics Review 2 March :57 PM.
Sympathetic Nervous System.
Pharmacology of the Peripheral Nervous System (PNS) Dr. Sabry Attia 2008.
Adrenergic agonists Saja Hamed, Ph.D.
Adrenergic Antagonists
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Adrenergic Agonists.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
(Cholinergic antagonists) (Anticholinergic ) (Cholinergic Blockers)
1 Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 17 & 18 Adrenergic Agonists & Antagonists.
Adrenergic Antagonists
Drugs Affecting the Autonomic Nervous System
INDIRECT CHOLINOMIMETICS Pharmacology Department
INDIRECT CHOLINOMIMETICS
Sympatholytic & adrenergic blockers -receptor Antagonists
Cholinergic Agents 10/01/1440 Saja Hamed, Ph.D.
Drugs for Autonomic Nervous System
Cholinesterase Inhibitors (Indirect acting cholinergic agonists)
Neurotransmitters SOMATIC NERVOUS SYSTEM Striated ACh muscle
Cholinergic Antagonist
Cholinergic Antagonist
Chapter 5 Autonomic Drugs.
INDIRECT CHOLINOMIMETICS
Adrenergic agonists and antagonists
Autonomic Nervous System
Sympatholytic & adrenergic blockers -receptor Antagonists
Copyright © 2011 by Elsevier Inc. All rights reserved.
Presentation transcript:

Peripheral Nervous System Drugs

Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular blockers Cholinesterase inhibitors: affects all cholinergic receptors

Parasympathetic Actions

Parasympathetic Receptors

Muscarinic Agonists (Parasympathomimetics) Limited uses: Urinary retention Increase GI peristalsis Glaucoma, eye surgery Adverse effects Bradycardia, hypotension Excess saliva, cramps, diarrhea Urinary (contra: bladder obstruction &surgery) Asthma exacerbation

Muscarinic Poisoning Sources Symptoms Treatment: atropine Muscarinic agonists Cholinesterase inhibitors Mushrooms Symptoms Profuse salivation, tearing, bronchospasm, diarrhea, bradycardia, hypotension Treatment: atropine

Muscarinic Antagonists (Parasympatholytics) “Anticholinergics” Agents Atropine: strongest, general use Oxybutinin (Ditropan): overactive bladder Tolerodine (Detrol): overactive bladder Scopolamine: sedation, motion sickness Ipratropium: lungs Dicyclomine (Bentyl): IBS, diarrhea Others: ophthalmic procedures, Parkinson’s

Atropine Mechanism: competitive blockade of muscarinic receptors. High doses will block nicotinic as well Pharmacologic effects: Heart: increase heart rate Exocrine Glands: decrease secretions Relaxation of smooth muscle Eye: mydriasis CNS excitation

Atropine Dose dependent Low dose Glands: sweat, salivary, bronchial High dose Glands: sweat, salivary, bronchial Heart Eye Bladder Intestine motility Lung Stomach

Atropine Kinetics: PO, topically (eye), injection Therapeutic Uses Preanesthesia Eye surgery Bradycardia Intestinal hypertonicity, hypermotility Muscarinic Agonist Poisoning

Adverse (Anticholinergic) Effects Xerostomia (Dry Mouth) Blurred vision, photophobia Elevation of IOP Urinary retention Constipation Anhidrosis (no sweat) Tachycardia Asthma: secretions too thick and crusty Dementia

Interactions Other drugs with anti-muscarinic effects Antihistamines Phenothiazine antipsychotics Tricyclic antidepressants

Anticholinergic Toxicity Dry as a bone Hot as a hare Blind as a bat Mad as a hatter **Must determine whether psychosis is real or anticholinergic Treatment: Minimize absorption Cholinesterase inhibitor

Cholinesterase Inhibitors Reversible Neostigmine: myasthenia gravis Physostigmine: anti-cholinergic antidote Irreversible Used as insecticides Developed in WW2 as “nerve gas” One is used for glaucoma

Myasthenia Gravis Etiology: Antibodies against Nicotinic-M receptors Clinical manifestations: fatigue, muscular weakness, dyspnea Treatment Cholinesterase inhibitors Side effects: can cause accumulation of acetylcholine and nicotinic-M and muscarinic receptors

Myasthenia Gravis Treatment Side effects cont Muscarinic effects Neuromuscular blockade (toxicity)

Neuromuscular Blockers Paralytics Repiratory depression, hypotension Agents Nondepolarizing: tubocurarine, et al. Depolarizing: succinylcholine Uses Surgery Mechanical Ventilation, ET intubation Adjunct to ECT

Sympathetic Actions

Sympathetic Receptors

Adrenergic Agonists Activate alpha and beta receptors Catecholamines: Broken down by MAO and COMT in liver and intestine Cannot be given orally, short half-life Epinephrine, Norepinephrine, isoproterenol, dopamine, dobutamine Colorless solutions; color is sign of oxidation

Adrenergic Agonists Noncatecholamines Can be given PO Last longer in body Ephedrine, phenylephrine, terbutaline

Receptor Specificity Dobutamine: Beta1 Terbutaline: beta2 Isoproterenol: beta1 & 2 Epinephrine: alpha 1 & 2, beta1 & 2 Relative selectivity Selectivity declines as concentration rises

Alpha1 Stimulation Therapeutic effects Adverse effects Vasoconstriction  hemostasis Nasal decongestion Local anesthesia adjunct Increase BP (intensive care, last resort) Mydriasis Adverse effects Hypertension Necrosis Bradycardia

Beta1 Activation Therapeutic Effects Adverse effects Cardiac arrest Heart Failure Shock A-V heart block Kidney? Adverse effects Altered HR, rhythm Angina pectoris

Beta2 activation Therapeutic Adverse effects Asthma Preterm labor Hyperglycemia Tremor

Epinephrine Receptors: all alpha and beta Therapeutic uses: Delay absorption of local anesthetics Control superficial bleeding Reduce nasal congestion Raise BP Mydriasis AV block Restart heart in cardiac arrest Asthma Anaphylactic shock

Epinephrine Abosrption Inactivation: MAO and COMT in liver Inhalation: minimal Injection Inactivation: MAO and COMT in liver Adverse events Hypertensive crisis Dysrythmias Angina pectoris Necrosis Hyperglycemia

Epinephrine Interactoins Preparations MAO inhibitors Tricyclic antidepressants Alpha-adrenergic blocking agents Beta-adrenergic blocking agents Preparations SC, IM, IV, Intracardiac, intraspinal, inhalation, Lidocaine with epi

Norepinephrine Receptor: alpha 1 & 2, beta1 Therapeutic uses Hypotensive state Cardiac arrest Brand: Levophed

Isoprotenerenol Receptors: Beta1 and Beta2 Uses Adverse effects AV block Shock Asthma (no longer used in U.S.) Bronchospasm (2° anesthesia) Adverse effects Dysrhythmias, angina pectoris Hyperglycemia

Dopamine Receptor: dopamine, alpha1, (beta1 high doses) Uses Shock: heart and renal arteries Heart failure ARF: low dose (some studies call effectiveness into question) Adverse Effects Dysrhythmias, angina pectoris

Other Adrenergic Agonists Dobutamine (beta1): heart failure Terbutaline: (beta2):preterm labor, asthma Phenylephrine: (alpha1) nasal congestion Ephedrine (all alpha and beta): Directly binds & ↑norepinephrine release Nasal congestion Narcolepsy Can be used to make amphetamines

Adrenergic Antagonists Can be quite selective for receptors

Alpha1-antagogonists Therapeutic uses Adverse effects Hypertension BPH Reverse toxicity of Pheochomocytoma Raynaud’s disease Adverse effects Orthostatic hypotension Reflex tachycardia Nasal Congestion Inhibition of ejaculation Na+ & H2O retention

Alpha-Adrenergic Blockers Prazosin - HTN Doxazosin – HTN, BPH Terazosin – HTN, BPH Tamsulosin – BPH Phentolamine – Pheochromocytoma, tissue necrosis

Beta-blockade Therapeutic Uses Adverse Effects (β1) Angina Pectoris HTN Dysrhythmias MI HF Other Hyperthyroid Migraine Stage Fright Pheochromocytoma Glaucoma Adverse Effects (β1) Bradycardia CO Precipitate HF AV heart block Rebound cardiac excitation Adverse Effects (β2) Bronchoconstriction Inhibition of glycogenolysis

Beta antagonists Beta1, Beta2 Selective Beta1,beta2, alpha1 Propanolol Nadolol Pindolol Selective Metoprolol Atenolol Bisoprolol Beta1,beta2, alpha1 Labetalol Carvedilol Used for HF Metoprolol

Indirect Adrenergic Antagonists Reserpine Suppresses NE synthesis and promotes MAO-mediated destruction Crosses BBB Effects Hypotension Adverse effects Depression, sedation, apathy Bradycardia, hypotension Guanethidine: similar but fewer CNS effect

Indirect Adrenergic Antagonists Clonidine Causes activation of alpha-2 receptors in CNS Uses Hypertension Pain relief in cancer (epdidural use only) Adverse effects Drowsiness, dry mouth, rebound HTN Preparations Oral: at least twice a day Transdermal: seven days

Indirect Adrenergic Antagonists Methyldopa, Methyldopate Similar to clonidine, but are taken up in brain stem neurons and converted to active alpha2 agonist Use: HTN Adverse effects 10 – 20% Positive Coombs test (5%) will go on to have hemolytic anemia Hepatotoxicity Drowsiness, dry mouth, hypotension, etc.